YAP1 and breast carcinoma: By categorizing breast cancer patients into normal and obese groups based on their obesity signature gene expression profiles (Figure S2A, Supporting Information), our analysis revealed several dysregulated pathways, notably the Hippo‐YAP signaling pathway, which was the most significantly upregulated in the obese group (Figure 1H).